Evaluating a New Iloperidone Titration Scheme in Bipolar I Disorder or Schizophrenia
Clinical trial NCT04127058 · COMPLETED
Trial details
- NCT number
- NCT04127058
- Sponsor
- Vanda Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-07
- Primary completion
- 2019-11-27
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.